SG Americas Securities LLC lowered its position in shares of Chemed Co. (NYSE:CHE) by 8.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,966 shares of the company’s stock after selling 387 shares during the period. SG Americas Securities LLC’s holdings in Chemed were worth $1,267,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Laurion Capital Management LP purchased a new position in shares of Chemed during the second quarter valued at $492,000. Marshall Wace LLP purchased a new position in shares of Chemed during the second quarter valued at $1,433,000. First Trust Advisors LP increased its stake in shares of Chemed by 370.3% during the third quarter. First Trust Advisors LP now owns 81,596 shares of the company’s stock valued at $26,076,000 after buying an additional 64,248 shares during the period. Virginia Retirement Systems ET AL increased its stake in shares of Chemed by 18.1% during the third quarter. Virginia Retirement Systems ET AL now owns 91,400 shares of the company’s stock valued at $29,210,000 after buying an additional 14,000 shares during the period. Finally, US Bancorp DE increased its stake in shares of Chemed by 2.3% during the third quarter. US Bancorp DE now owns 16,755 shares of the company’s stock valued at $5,355,000 after buying an additional 376 shares during the period. Hedge funds and other institutional investors own 88.06% of the company’s stock.
In related news, Director Donald E. Saunders sold 300 shares of the firm’s stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $308.74, for a total transaction of $92,622.00. Following the sale, the director now owns 8,251 shares of the company’s stock, valued at $2,547,413.74. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Naomi C. Dallob sold 5,500 shares of the firm’s stock in a transaction dated Wednesday, November 7th. The shares were sold at an average price of $317.23, for a total value of $1,744,765.00. Following the sale, the vice president now directly owns 11,122 shares in the company, valued at approximately $3,528,232.06. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 24,953 shares of company stock worth $7,678,463. 4.90% of the stock is owned by corporate insiders.
CHE has been the topic of several research reports. Bank of America initiated coverage on Chemed in a research note on Friday, October 12th. They set a “buy” rating and a $390.00 price target on the stock. Zacks Investment Research lowered Chemed from a “buy” rating to a “hold” rating in a research note on Tuesday, September 25th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $332.00.
Shares of Chemed stock opened at $302.95 on Friday. Chemed Co. has a 12 month low of $234.00 and a 12 month high of $335.99. The firm has a market cap of $4.90 billion, a PE ratio of 26.94, a PEG ratio of 2.68 and a beta of 1.18. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.11 and a current ratio of 1.14.
Chemed (NYSE:CHE) last issued its quarterly earnings data on Monday, October 29th. The company reported $3.07 earnings per share for the quarter, beating analysts’ consensus estimates of $2.80 by $0.27. Chemed had a return on equity of 35.13% and a net margin of 11.73%. The company had revenue of $444.15 million for the quarter, compared to the consensus estimate of $445.16 million. During the same quarter last year, the company earned $2.15 earnings per share. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. Sell-side analysts predict that Chemed Co. will post 11.41 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, December 3rd. Investors of record on Monday, November 12th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 0.40%. The ex-dividend date was Thursday, November 8th. Chemed’s payout ratio is currently 22.39%.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.
Recommended Story: Balanced Fund
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.